Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 4,571 | 4,535 | 4,700 | 5,068 | 5,598 | 4,911 | 5,537 | 5,854 | 6,405 | 6,336 | | 6,336 |
% Growth | NA | -0.8% | 3.6% | 7.8% | 10.5% | -12.3% | 12.8% | 5.7% | 9.4% | -1.1% | | |
| | | | | | | | | | | | |
Cost of Revenue | (3,903) | (3,843) | (3,975) | (4,513) | (4,697) | (4,028) | (4,616) | (5,018) | (5,400) | (5,372) | | (5,372) |
Gross Profit | 669 | 692 | 725 | 555 | 901 | 883 | 921 | 835 | 1,005 | 964 | | 964 |
% Revenue | 14.6% | 15.3% | 15.4% | 10.9% | 16.1% | 18.0% | 16.6% | 14.3% | 15.7% | 15.2% | | 15.2% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | (0) | (1) | (1) | (1) | (0) | (0) | (0) | (0) | | (0) |
Selling and Marketing | (134) | (148) | (173) | (188) | (198) | (208) | (200) | (199) | (203) | (197) | | (197) |
General and Admin | (291) | (374) | (385) | (403) | (422) | (426) | (447) | (392) | (516) | (511) | | (511) |
Other Inc / (Exp) | (171) | (11) | (133) | 80 | 41 | 285 | (125) | (729) | (316) | (113) | | (113) |
Total Operating Exp | (596) | (533) | (692) | (512) | (579) | (350) | (772) | (1,321) | (1,036) | (822) | | (822) |
| | | | | | | | | | | | |
Operating Income | 73 | 159 | 33 | 43 | 322 | 533 | 149 | (485) | (30) | 142 | | 142 |
% Revenue | 1.6% | 3.5% | 0.7% | 0.9% | 5.8% | 10.9% | 2.7% | -8.3% | -0.5% | 2.2% | | 2.2% |
| | | | | | | | | | | | |
Interest Expense | 497 | 522 | 595 | 446 | 367 | 245 | 345 | 186 | 433 | 292 | | 292 |
Pre-tax Income | 570 | 681 | 627 | 489 | 689 | 778 | 494 | (299) | 403 | 435 | | 435 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (37) | (47) | (72) | (60) | (56) | (184) | (102) | 45 | (99) | (106) | | (106) |
Net Income to Company | 533 | 634 | 556 | 429 | 634 | 594 | 392 | (254) | 304 | 328 | | 328 |
% Margin | 11.7% | 14.0% | 11.8% | 8.5% | 11.3% | 12.1% | 7.1% | -4.3% | 4.7% | 5.2% | | 5.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (72) | (86) | (81) | 49 | (107) | (79) | (89) | (79) | (91) | (95) | | (95) |
Net Income to Stockholders | 461 | 548 | 474 | 478 | 526 | 515 | 303 | (333) | 213 | 233 | | 233 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 461 | 548 | 474 | 478 | 526 | 515 | 303 | (333) | 213 | 233 | | 233 |
% Margin | 10.1% | 12.1% | 10.1% | 9.4% | 9.4% | 10.5% | 5.5% | -5.7% | 3.3% | 3.7% | | 3.7% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.19 | 0.22 | 0.16 | 0.16 | 0.18 | 0.17 | 0.10 | (0.11) | 0.07 | 0.08 | | 0.08 |
Diluted EPS (Continuing Ops) | 0.19 | 0.22 | 0.16 | 0.16 | 0.18 | 0.17 | 0.10 | (0.11) | 0.07 | 0.08 | | 0.08 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 2,427.02 | 2,489.29 | 2,963.33 | 2,952.43 | 2,952.43 | 2,952.43 | 2,952.43 | 2,952.43 | 2,952.43 | 2,952.45 | | 2,952.45 |
WA Diluted Shares Out. | 2,427.02 | 2,489.29 | 2,963.33 | 2,952.43 | 2,952.43 | 2,952.43 | 2,952.43 | 2,952.43 | 2,952.43 | 2,952.45 | | 2,952.45 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 570 | 681 | 627 | 489 | 689 | 778 | 494 | (299) | 403 | 435 | | 435 |
Addback: Net Interest Expense | (497) | (522) | (595) | (446) | (367) | (245) | (345) | (186) | (433) | (292) | | (292) |
Addback: Other Non Operating Expenses, Total | (5) | (11) | 113 | (50) | 8 | 126 | 57 | (107) | (1) | 159 | | 159 |
Addback: Depreciation & Amortization | 326 | 354 | 369 | 405 | 372 | 346 | 331 | 339 | 341 | 371 | | 371 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | (5) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 22 | 2 | (14) | (51) | (75) | (415) | 83 | 868 | 349 | (25) | | (25) |
Addback: Gain (Loss) On Sale Of Assets | 9 | 13 | 12 | 8 | 1 | (0) | (1) | (25) | (16) | (12) | | (12) |
Addback: Asset Writedown | 52 | 0 | 0 | 0 | 17 | 0 | 0 | 5 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 66 | (32) | (6) | (15) | (21) | (8) | (33) | (30) | (30) | 0 | | 0 |
Adjusted EBITDA | 542 | 486 | 500 | 340 | 624 | 583 | 587 | 564 | 612 | 636 | | 636 |
% Margin | 11.9% | 10.7% | 10.6% | 6.7% | 11.1% | 11.9% | 10.6% | 9.6% | 9.6% | 10.0% | | 10.0% |
| | | | | | | | | | | | |
Adjusted EBIT | 217 | 131 | 132 | (64) | 252 | 237 | 257 | 225 | 271 | 264 | | 264 |
% Margin | 4.7% | 2.9% | 2.8% | -1.3% | 4.5% | 4.8% | 4.6% | 3.8% | 4.2% | 4.2% | | 4.2% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 533 | 634 | 556 | 429 | 634 | 594 | 392 | (254) | 304 | 328 | | 328 |
Addback: Unusual Items | 148 | (17) | (14) | (57) | (78) | (423) | 50 | 818 | 302 | (36) | | (36) |
Less: Tax Benefit of Unusual Items (26%) | (39) | 4 | 4 | 15 | 20 | 110 | (13) | (213) | (79) | 9 | | 9 |
Adjusted Net Income | 643 | 622 | 545 | 387 | 576 | 282 | 430 | 351 | 527 | 301 | | 301 |
% Margin | 14.1% | 13.7% | 11.6% | 7.6% | 10.3% | 5.7% | 7.8% | 6.0% | 8.2% | 4.8% | | 4.8% |